GMED - Globus Medical Inc Stock Price, Fair Value and News

71.89USD+0.14 (+0.20%)Market Closed

Market Summary

USD71.89+0.14

Market Closed

0.20%

GMED Stock Price

View Fullscreen

GMED RSI Chart

GMED Valuation

Market Cap

9.7B

Price/Earnings (Trailing)

145.06

Price/Sales (Trailing)

5.1

EV/EBITDA

32.5

Price/Free Cashflow

63.87

GMED Price/Sales (Trailing)

GMED Profitability

EBT Margin

4.93%

Return on Equity

1.7%

Return on Assets

1.35%

Free Cashflow Yield

1.57%

GMED Fundamentals

GMED Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

119.26%

Rev. Growth (Qtr)

-1.6%

GMED Earnings

Earnings (TTM)

66.8M

Earnings Growth (Yr)

-114.49%

Earnings Growth (Qtr)

-147.9%

Breaking Down GMED Revenue

Last 7 days

-0.3%

Last 30 days

6.4%

Last 90 days

41.9%

Trailing 12 Months

15.2%

How does GMED drawdown profile look like?

GMED Financial Health

Current Ratio

2.33

Debt/Equity

0.11

Debt/Cashflow

0.58

GMED Investor Care

Shares Dilution (1Y)

34.61%

Diluted EPS (TTM)

0.58

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.9B	0	0	0
2023	1.1B	1.1B	1.2B	1.6B
2022	961.3M	973.9M	998.4M	1.0B
2021	825.8M	927.9M	941.5M	958.1M
2020	793.0M	747.4M	767.3M	789.0M
2019	721.5M	742.7M	769.6M	785.4M
2018	654.6M	675.6M	693.1M	713.0M
2017	580.5M	595.4M	611.5M	636.0M
2016	552.4M	556.3M	555.0M	564.0M
2015	491.8M	511.8M	531.0M	544.8M
2014	443.7M	450.2M	460.8M	474.4M
2013	396.3M	407.3M	419.8M	434.5M
2012	347.9M	363.0M	373.5M	386.0M
2011	299.0M	309.8M	320.7M	331.5M
2010	0	0	0	288.2M

Get all data in R, Python etc through our Historical Stock Data APIs

About Globus Medical Inc

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. The company sells its products through direct or distributor sales presence, as well as its hip and knee products primarily through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

CEO	Mr. Daniel T. Scavilla
WEBSITE	globusmedical.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	2600

Globus Medical Inc Frequently Asked Questions

What is the ticker symbol for Globus Medical Inc? What does GMED stand for in stocks?

GMED is the stock ticker symbol of Globus Medical Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Globus Medical Inc (GMED)?

As of Thu Jul 25 2024, market cap of Globus Medical Inc is 9.69 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of GMED stock?

You can check GMED's fair value in chart for subscribers.

Is Globus Medical Inc a good stock to buy?

The fair value guage provides a quick view whether GMED is over valued or under valued. Whether Globus Medical Inc is cheap or expensive depends on the assumptions which impact Globus Medical Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for GMED.

What is Globus Medical Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jul 25 2024, GMED's PE ratio (Price to Earnings) is 145.06 and Price to Sales (PS) ratio is 5.1. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. GMED PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Globus Medical Inc's stock?

In the past 10 years, Globus Medical Inc has provided 0.122 (multiply by 100 for percentage) rate of return.